K. Sugano and J. Tack, The Stomach in Health and Disease, Gut, vol.2015, issue.10, pp.1650-1668

E. Touati, V. Michel, J. M. Thiberge, N. Wuscher, M. Huerre et al., Chronic Helicobacter Pylori Infections Induce Gastric Mutations in Mice, Gastroenterology, vol.124, issue.5, pp.1408-1419, 2003.

, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

L. Schistosomes, H. Flukes, and . Pylori, Volume 61; International Agency for Research on Cancer (lARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol.61, 1994.

L. H. Eusebi, R. M. Zagari, and F. Bazzoli, Epidemiology of Helicobacter Pylori Infection, Helicobacter, vol.19, issue.S1, pp.1-5, 2014.

S. E. Roberts, S. Morrison-rees, D. G. Samuel, K. Thorne, A. Akbari et al., Review Article: The Prevalence of Helicobacter Pylori and the Incidence of Gastric Cancer across Europe, Aliment. Pharmacol. Ther, vol.43, issue.3, pp.334-345, 2016.

A. Mentis, P. Lehours, and F. Mégraud, Epidemiology and Diagnosis of Helicobacter Pylori Infection, Helicobacter, vol.20, pp.1-7, 2015.

, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Part B: Biological Agents; International Agency for Research on Cancer (IARC Monographs on the Evaluation of Carcinogenic Risk to Human, 2012.

K. Sugano, J. Tack, E. J. Kuipers, D. Y. Graham, E. M. El-omar et al., P. Kyoto Global Consensus Report on Helicobacter Pylori Gastritis. Gut, pp.1-15, 2015.

P. Malfertheiner, F. Megraud, C. O'morain, J. Atherton, A. T. Axon et al., , pp.40-53

F. Gensini, G. F. Gisbert, J. P. Graham, D. Y. Rokkas, and T. ,

E. M. Omar and E. J. Kuipers, The European Helicobacter Study Group. Management of Helicobacter Pylori Infection-the Maastricht IV/ Florence Consensus Report, Gut, vol.2012, issue.5, pp.646-664

, Helicobacter Pylori Eradication as a Strategy for Preventing Gastric Cancer; International Agency for Research on Cancer, 2014.

W. K. Leung, I. O. Wong, K. S. Cheung, K. F. Yeung, E. W. Chan et al., Effects of Helicobacter Pylori Treatment on Incidence of Gastric Cancer in Older Individuals, Gastroenterology, vol.155, issue.1, pp.67-75, 2018.

A. O'connor, C. A. O'morain, and A. C. Ford, Population Screening and Treatment of Helicobacter Pylori Infection, Nat. Rev. Gastroenterol. Hepatol, vol.14, pp.230-240, 2017.

F. Franceschi, A. Tortora, T. Di-rienzo, G. D´angelo, G. Ianiro et al., Helicobacter Pylori Infection on Nutrition and Metabolism. World J. Gastroenterol, vol.20, issue.36, pp.12809-12817, 2014.

F. Franceschi, A. Gasbarrini, S. A. Polyzos, and J. Kountouras, Extragastric Diseases and Helicobacter Pylori, Helicobacter, vol.20, pp.40-46, 2015.

P. Malfertheiner, F. Megraud, C. A. O'morain, J. P. Gisbert, E. J. Kuipers et al., European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter Pylori Infection-the Maastricht V/Florence Consensus, pp.41-53

S. M. Smith, C. O'morain, and D. Mcnamara, Antimicrobial Susceptibility Testing for Helicobacter Pylori in Times of Increasing Antibiotic Resistance, World J. Gastroenterol, vol.20, issue.29, pp.9912-9921, 2014.

M. Safavi, R. Sabourian, and A. Foroumadi, Treatment of Helicobacter Pylori Infection: Current and Future Insights, World J. Clin. Cases, vol.2016, issue.1, pp.5-19

M. M. Gerrits, A. H. Van-vliet, E. J. Kuipers, and J. G. Kusters, Helicobacter Pylori and Antimicrobial Resistance: Molecular Mechanisms and Clinical Implications, Lancet Infect Dis, vol.6, issue.11, pp.699-709, 2006.

E. Tacconelli, E. Carrara, A. Savoldi, S. Harbarth, M. Mendelson et al., Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis, vol.18, pp.318-327, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02347423

A. Debraekeleer and H. Remaut, Future Perspective for Potential Helicobacter Pylori Eradication Therapies, Future Microbiol, vol.13, issue.6, pp.671-687, 2018.

A. Savoldi, E. Carrara, D. Y. Graham, M. Conti, and E. Tacconelli, Prevalence of Antibiotic Resistance in Helicobacter Pylori: A Systematic Review and Meta-Analysis in World Health Organization Regions, Gastroenterology, vol.155, issue.5, pp.1372-1382, 2018.

G. Del-giudice, P. Malfertheiner, and R. Rappuoli, Development of Vaccines against Helicobacter Pylori, Expert Rev. Vaccines, vol.8, issue.8, pp.1037-1049, 2009.

A. T. Abadi, Vaccine against Helicobacter Pylori: Inevitable Approach, World J. Page, vol.42, p.53

A. Blosse, P. Lehours, K. T. Wilson, and A. P. Gobert, Helicobacter: Inflammation, Immunology, and Vaccines, Helicobacter, vol.23, p.12517, 2018.

V. Papastergiou, S. D. Georgopoulos, and S. Karatapanis, Treatment of Helicobacter Pylori Infection: Meeting the Challenge of Antimicrobial Resistance, World J. Gastroenterol, vol.20, issue.29, pp.9898-9911, 2014.

C. Follmer, Ureases as a Target for the Treatment of Gastric and Urinary Infections, J Clin Pathol, vol.63, issue.5, pp.424-430, 2010.

N. R. Neelapu, N. V. Mutha, and S. Akula, Identification of Potential Drug Targets in Helicobacter Pylori Strain HPAG1 by in Silico Genome Analysis

. Disord, Drug Targets, vol.15, pp.106-117, 2015.

J. Freigang, K. Diederichs, K. P. Schäfer, W. Welte, and R. Paul, Crystal Structure of Oxidized Flavodoxin, an Essential Protein in Helicobacter Pylori, Protein Sci, vol.11, pp.253-261, 2002.

M. Mart?ínez-júlvez, N. Cremades, M. Bueno, I. Pérez-dorado, C. Maya et al., Common Conformational Changes in Flavodoxins Induced by FMN and Anion Binding: The Structure of Helicobacter Pylori Apoflavodoxin, Proteins, vol.69, pp.581-594, 2007.

N. Cremades, A. Velazquez-campoy, E. Freire, and J. Sancho, The Flavodoxin from Helicobacter Pylori: Structural Determinants of Thermostability and FMN Cofactor Binding, Biochemistry, vol.47, issue.2, pp.627-639, 2008.

S. Ayuso-tejedor, R. García-fandiño, M. Orozco, J. Sancho, and P. Bernadó, Structural Analysis of an Equilibrium Folding Intermediate in the Apoflavodoxin Native Ensemble by Small-Angle X-Ray Scattering, J. Mol. Biol, vol.406, issue.4, 2011.

J. Sancho, Flavodoxins: Sequence, Folding, Binding, Function and Beyond, Cell. Mol. Life Sci, vol.63, pp.855-864, 2006.

Á. Rodríguez-cárdenas, A. L. Rojas, M. Conde-giménez, A. Velázquez-campoy, R. Hurtado-guerrero et al., Streptococcus Pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target, PLoS One, vol.11, issue.9, pp.1-25, 2016.

N. J. Hughes, P. A. Chalk, C. L. Clayton, and D. J. Kelly, Identification of Carboxylation Enzymes and Characterization of a Novel Four-Subunit Pyruvate:flavodoxin Oxidoreductase from Helicobacter Pylori, J. Bacteriol, vol.177, issue.14, pp.3953-3959, 1995.

. St, M. Maurice, N. Cremades, M. A. Croxen, G. Sisson et al., Quinone Reductase (FqrB): A Redox Partner of Pyruvate:Ferredoxin Oxidoreductase That Reversibly Couples Pyruvate Oxidation to NADPH Production in Helicobacter Pylori and Campylobacter Jejuni, J. Bacteriol, vol.189, issue.13, pp.4764-4773, 2007.

N. J. Hughes, C. L. Clayton, P. A. Chalk, and D. J. Kelly, Helicobacter Pylori porCDAB and oorDABC Genes Encode Distinct Pyruvate:Flavodoxin and 2-Oxoglutarate:Acceptor Oxidoreductases Which Mediate Electron Transport to NADP, J. Bacteriol, vol.180, issue.5, pp.1119-1128, 1998.

N. Cremades, M. Bueno, M. Toja, and J. Sancho, Towards a New Therapeutic Target: Helicobacter Pylori Flavodoxin, Biophys. Chem, vol.115, issue.2-3, pp.267-276, 2005.

N. Cremades, M. Bueno, J. L. Neira, A. Velázquez-campoy, and J. Sancho, Conformational Stability of Helicobacter Pylori Flavodoxin Fit to Function at pH 5, vol.44, p.53

N. Cremades, A. Velazquez-campoy, M. Martinez-julvez, J. L. Neira, I. Perez-dorado et al., Discovery of Specific Flavodoxin Inhibitors as Potential Therapeutic Agents against Helicobacter Pylori Infection, ACS Chem. Biol, vol.4, issue.11, pp.928-938, 2009.

J. J. Galano, M. Alías, R. Pérez, A. Velázquez-campoy, P. S. Hoffman et al., Improved Flavodoxin Inhibitors with Potential Therapeutic Effects against Helicobacter Pylori Infection, J. Med. Chem, vol.56, issue.15, pp.6248-6258, 2013.

D. I. Edwards, Nitroimidazole Drugs -Action and Resistance Mechanisms I. Mechanisms of Action, J. Antimicrob. Chemother, vol.31, pp.9-20, 1993.

I. N. Olekhnovich, A. Goodwin, and P. S. Hoffman, Characterization of the NAD(P)H Oxidase and Metronidazole Reductase Activities of the RdxA Nitroreductase of Helicobacter Pylori, FEBS J, vol.276, issue.12, pp.3354-3364, 2009.

M. Martínez-júlvez, A. L. Rojas, I. Olekhnovich, V. Espinosa-angarica, P. S. Hoffman et al., Structure of RdxA: An Oxygen Insensitive Nitroreductase Essential for Metronidazole Activation in Helicobacter Pylori, FEBS J, vol.2012, issue.23, pp.4306-4317

C. W. Ang, A. M. Jarrad, M. A. Cooper, and M. A. Blaskovich, Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases, J. Med. Chem, vol.60, pp.7636-7657, 2017.

U. Kessler, D. Castagnolo, M. Pagano, D. Deodato, M. Bernardini et al., Discovery and Synthesis of Novel Benzofurazan Derivatives as Inhibitors of Influenza A Virus, Bioorganic Med. Chem. Lett, vol.23, pp.5575-5577, 2013.

K. Sinhababu-achintya and T. Boschardt-ronald, Silica Gel-Assisted Reduction of Nitrostyrenes to 2-Aryl-1-Nitroalkanes with Sodium Borohydride, Tetrahedron Lett, vol.24, issue.3, pp.227-230, 1983.

R. J. Rahaim and R. E. Maleczka, Palladium-Catalyzed Silane/Siloxane Reductions in the One-Pot Conversion of Nitro Compounds into Their Amines, Hydroxylamines, Amides, Sulfonamides, and Carbamates. Synthesis (Stuttg), pp.3316-3340, 2006.

R. R. Holmes and R. P. Bayer, A Simple Method for the Direct Oxidation of Aromatic Amines to Nitroso Compounds, J. Am. Chem. Soc, vol.82, issue.13, pp.3454-3456, 1960.

E. Kun, M. Valley, J. Mendeleyev, and . Patent, , 1996.

V. Iaroshenko, D. Sevenard, D. Volochnyuk, Y. Wang, A. Martiloga et al., Facile Synthesis of Fluorinated 1-Desazapurines. Synthesis (Stuttg), vol.11, pp.1865-1875, 2009.

J. P. Gisbert, J. Molina-infante, J. Amador, F. Bermejo, L. Bujanda et al., IV Spanish Consensus Conference on Helicobacter Pylori Infection Treatment, vol.39, pp.697-721, 2016.

A. Lee, J. O'rourke, M. C. De-ungria, B. Robertson, G. Daskalopoulos et al., Standardized Mouse Model of Helicobacter Pylori Infection: Introducing the Sydney Strain, Gastroenterology, vol.112, issue.4, pp.1386-1397, 1997.

M. Correia, V. Michel, A. A. Matos, P. Carvalho, M. J. Oliveira et al., Docosahexaenoic Acid Inhibits Helicobacter Pylori Growth In Vitro and Mice Page, vol.46, p.53

, Gastric Mucosa Colonization, PLoS One, vol.7, p.35072, 2012.

A. Velazquez-campoy, J. Sancho, O. Abian, and S. Vega, Biophysical Screening for Identifying Pharmacological Chaperones and Inhibitors Against Conformational and Infectious Diseases, Curr. Drug Targets, vol.17, issue.13, pp.1492-1505, 2016.

M. Müller, Mode of Action of Metronidazole on Anaerobic Bacteria and Protozoa, Surgery, vol.93, issue.1, pp.165-171, 1983.

D. I. Edwards, Mechanisms of Selective Toxicity of Metronidazole and Other Nitroimidazole Drugs, Br. J. Vener. Dis, vol.56, issue.5, pp.285-290, 1980.

D. I. Edwards, Nitroimidazole Drugs -Action and Resistance Mechanisms II. Mechanisms of Resistance, J. Antimicrob. Chemother, vol.31, issue.2, pp.201-210, 1993.

K. M. Keeney, S. Yurist-doutsch, M. Arrieta, and B. B. Finlay, Effects of Antibiotics on Human Microbiota and Subsequent Disease, Annu. Rev. Microbiol, vol.68, pp.217-235, 2014.

J. F. Tomb, O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton et al., Nature, vol.389, issue.6649, p.412, 1997.